AI 요약
xeljanz에 대한 실시간 결과 8개를 검토하고, 먼저 비교할 가치가 높은 3개의 옵션로 좁혔습니다.
이 후보 목록에서 가장 강한 주제는 Pharmaceutical 및 Extended Release Tablets입니다.
Compare with TopFind
라이브 검색
라이브 결과 로딩 중
TopFind가 검색어에 맞는 최신 결과를 가져오고 있습니다.
라이브 검색
TopFind가 검색어에 맞는 최신 결과를 가져오고 있습니다.
xeljanz에 대한 실시간 결과 8개를 검토하고, 먼저 비교할 가치가 높은 3개의 옵션로 좁혔습니다.
이 후보 목록에서 가장 강한 주제는 Pharmaceutical 및 Extended Release Tablets입니다.
출처: Pfizer (Thailand) Ltd.
설명
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
추천 대상
Once Daily dosing, Long Term maintenance 및 Chronic inflammation management
평점
출처: Pfizer (Thailand) Ltd.
설명
XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA.
추천 대상
Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions 및 Official brand preference
평점
출처: Pfizer Thailand
설명
Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals.
추천 대상
Patients in Thailand, Innovator drug preference, Insured medical treatments 및 Hospital Based pharmacy users
평점
| 비교 | XELJANZ XR | XELJANZ | Xeljanz (Tofacitinib) |
|---|---|---|---|
| 출처 | Pfizer (Thailand) Ltd. | Pfizer (Thailand) Ltd. | Pfizer Thailand |
| 설명 | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA. | Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals. |
| 추천 대상 | Once Daily dosing, Long Term maintenance 및 Chronic inflammation management | Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions 및 Official brand preference | Patients in Thailand, Innovator drug preference, Insured medical treatments 및 Hospital Based pharmacy users |
| 작업 | |||
| 평점 |
가장 균형 잡힌 옵션부터 보고 싶다면 다음을 추천합니다:
"XELJANZ XR 출처 Pfizer (Thailand) Ltd.."
이 항목을 선택한 이유는 Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.